ABOUT CSL
CSL is a leading global biotechnology company with a constantly evolving portfolio of lifesaving products, built from the company’s passion to always put patients and people first.
Headquartered in Melbourne and listed on the Australian Stock Exchange, CSL provides life-saving medicines in more than 60 countries and has over 32,000 employees worldwide. Innovation and growth is a priority for CSL, and its exceptional track record of year-on-year growth and shareholder return coupled with sustained patient impact have garnered CSL a strong reputation across its broad and diverse stakeholder base.
OUR CORE CSL BUSINESSES
CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in U.S., Europe and China. Plasma collected at CSL Plasma facilities are used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
CSL Seqirus was established in 2015 from the joining of bioCSL, CSL’s former influenza division and the legacy Novartis Influenza Vaccines business. Together the two elevated Seqirus to the second largest influenza company in the world. Seqirus today is a global vaccines leader with one of the broadest influenza vaccine portfolios, and a growing suite of vaccine technologies for COVID-19 and other respiratory pathogens.
CSL Vifor is a strong and rapidly growing presence in nephrology and is committed to launching the next generation of therapies to address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by their founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need.
RESPONSIBILITIES
The Head, CSL Vifor Policy, Advocacy & Government Affairs leads the development and execution of policy and public affairs plans to enable the achievement of CSL Vifor’s business ambitions today and into the future, and to maintain and grow CSL Vifor’s profile as a leader in the biopharmaceutical industry.
The role serves as the company’s senior representative for CSLV with public affairs stakeholders.
The role is responsible for ensuring organizational awareness of and ability to shape government legislation and/or regulatory issues that affect the success of CSLV.
The role will design and oversee execution of plans to advance CSLV’s priorities in the public affairs realm by drawing on and directing CEA team members and resources in key geographies.
The person in this role will be responsible for the following:
Develops and lead execution of PAGA plans to drive CSLV priorities in key geographies, with a focus on Patient Blood Management and maximizing the value of the CSLV portfolio.
Leads and coordinates company engagement with government officials, industry associations, patient associations and other stakeholders in relevant policy matters
Leads the communication of business-relevant policy updates to senior company leaders
Partners with key functions, including CSLV Market Access, Marketing, Medical, and Regulatory, and CEA teams in key geographies, to develop and execute plans
Leads engagement for CSLV in Switzerland with government officials, industry associations, and other stakeholders, and coordinates public affairs activities across CSL business units’ (CSL Behring, CSL Seqirus, and CSL Vifor).
Develops and leads execution of engagement plan to ensure strong relationships with public affairs stakeholders where CSL Vifor has a significant presence
QUALIFICATIONS
Graduate/professional degree in law, public health, or similar disciplines preferred.
Minimum 15 years of experience in healthcare policy/public affairs or comparable fields
Experience designing and leading global efforts to manage public affairs issues, and to build company profile and impact with important healthcare public affairs stakeholders in key geographies including the US and Europe
Experience collaborating with colleagues at multiple levels of the organization to align on and execute shared goals
Strong understanding of the workings of major healthcare industry associations
Experience partnering with third-party stakeholders to advance shared goals
Strong network of relationships with government officials, industry, and other stakeholders that are influential in shaping policy that can affect CSLV priorities, including patient blood management.
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
As a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.